Read + Share
Amedeo Smart
Independent Medical Education
Kircik LH, Alonso-Llamazares J, Bhatia N, Bukhalo M, et al. Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study. Br J Dermatol 2023 Jun 5:ljad182. doi: 10.1093.PMID: 37279795
Email
LinkedIn
Facebook
Twitter
Privacy Policy